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Abstract
Background: The enhanceosome is an enhancer located upstream of the human interferon β gene, bound by
transcription factor (TF) complex of extremely rigid structure. Within these rigid constraints, even a slight change of
distances between transcription factor binding sites (TFBS) results in loss of functionality of the enhanceosome. We
hypothesized that smaller subunits of the enhanceosomemay entail TF complex formation in other regulatory regions.
Results: In order to verify this hypothesis we systematically searched for dimerization preferences of the TFs that have
TFBS in the enhanceosome. For this we utilized our recently developed tool, TACO. We performed this computational
experiment in a cell-type–specific manner by utilizing cell-type–specific DNase-seq data for 105 human cell types. We
also used 20 TRANSFAC motifs comprising not only the usual TFs constituting the enhanceosome but also the
architectural proteins of High Mobility Group I(Y) (HMG I). A similar experiment used 42 DNase-seq data sets for mouse
cell types. We found 137 statistically significant dimer predictions in the human genome, and 37 predictions in the
mouse genome, that matched the positioning on the enhanceosome with ±2 bp tolerance. To characterize these
predicted TF dimers, we performed functional analysis (Gene Ontology enrichment) for sets of genes which were in
the neighbourhood of predicted dimer instances. A notable feature of these instances is that (1) most of them are
located in introns of genes, (2) they are enriched in regulatory states, and (3) those instances that are located near
transcription start sites are enriched for inclusion in computationally predicted enhancers. We also investigated
similarity of dimer predictions between human and mouse.
Conclusions: It follows from our experiments that, except for homodimer formed by IRF proteins, the rest of the
dimers were formed exclusively between one of the transcriptional activators (ATF-2/c-Jun and IRF) and a HMG I
protein. NF-κB did not participate in forming dimers with other proteins. Dimers predicted in mouse were fully
contained in those predicted in human, with exactly the same spacing and orientation. Intriguingly, in most of the
cases the enhanceosome motifs have 1 bp wider spacing than the corresponding dimers predicted genome-wide,
which is likely caused by the overall 3D structure constraints of the enhanceosome-bound complex.
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Background
Transcriptional activation of the human interferon β
(IFN-β) gene is governed by an enhancer, termed the
enhanceosome. This enhancer is located in the human
genome on chromosome 9 and forms a region of length 57
bp, which is 44 bp upstream of IFN-β . The enhanceosome
is one of the best studied enhancers [1]. It is an excellent
example of combinatorial interaction between distinct
regulatory elements. This enhancer is bound by NF-κB
(p50/RelA), ATF-2/c-Jun and interferon regulatory factor
(IRF) proteins. The first two proteins are heterodimers.
All together these transcriptional activators have well
characterized eight binding sites in the enhanceosome
(the heterodimers occupy two binding sites, each, and
IRFs occupy four binding sites); see [1] for a review. NF-κB
and ATF-2/c-Jun proteins recognize two positive regula-
tory domains (PRDs): PRD II and PRD IV, respectively,
while IRFs recognize the other two domains: PRD I and
PRD III. Notably, many neighbouring binding sites in the
enhanceosome overlap.
The process of activation of interferon β is quite intri-
cate and highly ordered as described for example in [2].
Since 2007 high resolution crystal structures that concern
portions of the enhanceosome with portions of relevant
transcription factors are known [3–5]. As a result of
molecular dynamics simulations of different motif com-
binations of the enhanceosome it was argued [6] that the
specificity of the enhancer is attained in this case via
cooperative binding of the neighbouring partners.
It was proposed by Arnosti and Kulkarni [7] that
enhancers exhibit a wide spectrum of adopted constraints
put on the structure of their transcription factor (TF)
binding sites, ranging from those with a very flexible
structure, termed billboards, and ending up in enhancers
with a very rigid structure, whose primary example is the
enhanceosome. Rigidity of the enhanceosome shows up
when one changes the arrangement of the transcription
factor binding sites (TFBS) of the involved transcriptional
activators of IFN-β : even slight change in distance or ori-
entation of TFBS results in a dramatic drop of the activity
of gene expression [2].
In addition to the above mentioned transcriptional acti-
vators, an important role in fine tuning the specificity
in gene expression is played by architectural proteins
of the mammalian high mobility group HMG I(Y) [8].
HMG I and HMG Y are alternative RNA splicing vari-
ants encoded by the same gene. It is known that the role
of HMG I(Y) proteins in the first step of enhanceosome
assembly is the recruitment of NF-κB and ATF-2/c-Jun
by allosteric changes induced in the DNA [8]. However,
in the second step, upon completion of the enhanceo-
some assembly process, it is required that HMG I(Y)
proteins form protein-protein interactions with the acti-
vators. HMG I(Y) proteins have three binding sites in
positive regulatory domains of the enhanceosome: two in
PRD IV, and one in PRD II, which we refer to as HMG-A,
HMG-B and HMG-C, respectively.
The functional role of the involved TFs on the level of
expression of IFN-β is not precisely determined yet. For
example it has been recently reported [9] that the role
of these TFs is not so symmetrical as one might expect.
The authors report that the role of IRFs is critical for the
expression of INF-β when performing an experiment in a
transgenic mouse, but it is not so with the NF-κB subunits
(p50 and RelA). In another work in the same vein [10] it
has been reported that the IFN-β enhanceosome region is
not sufficient for maximal gene induction in response to
stimulation with bacterial lipopolysaccharide (LPS). This
study also identified a cluster of NF-κB sites in the 3’
downstream region of the gene.
Given the above remarks, we set out a hypothesis
that smaller subunits of the enhanceosome may entail
TF complex formation in other regulatory regions. More
specifically we want to investigate which dimers (pairs of
proteins) involved in enhanceosome assembly (transcrip-
tional activators and architectural proteins) are preferably
used in other regulatory elements.
In order to address these questions we applied TACO
[11], our recently developed tool to predict TF dimers
from DNA sequence by incorporating position weight
matrices (PWMs) and information about regions of open
chromatin. The selection of statistically overrepresented
dimer structures (as defined by a pair of PWMs, offset
between TFBS, and their mutual orientation) is done in a
cell-type–specific manner, as described earlier [12]. Here,
we consider 20 TRANSFAC motifs [13] that represent
transcriptional activators and HMG I(Y) binding affinities
with hits in the enhanceosome.We also used in this exper-
iment DNase-seq data for 105 human cell types.We found
137 dimer predictions that matched the positioning on the
enhanceosome with ±2 bp tolerance.
Analysis of the above mentioned computational experi-
ment suggests the following key observations: (1) among
transcriptional activators only the IRF proteins form a
homodimer that is utilized on a genome-wide scale, (2)
all other predicted dimers involve HMG I(Y) proteins and
ATF-2/c-Jun or IRF transcription factors, (3) the majority
of dimer instances is located within introns of genes.
We also repeated the same experiment with mouse
genome and mouse DNase-seq data for 42 cell types.
In this case, 37 predictions matched those present in
the mouse enhanceosome with ±2 bp tolerance. The
key observations for the mouse enhanceosome are sim-
ilar to the above observations for human. A noticeable
relation linking predictions in human and in mouse is
that even though the latter form a subset of the former,
every predicted dimer structure in mouse is also pre-
dicted in human with exactly the same arrangement. It is
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Fig. 1Motif hits along the enhanceosome sequence. For the selected 20 TRANSFAC PWMs, their hits (including orientation) are presented along the
enhanceosome sequence. Colored rectangles represent binding sites of the enhanceosome activators as reported by [4]. It should be noted that in
most cases a PWM represents binding affinity for a dimer
also noteworthy that genes that contain predicted dimer
instances in human and in mouse have similar GO term
annotations (p-value < 1.0e − 7, Fisher’s exact test).
Results
Predicted dimers in various cell types
For our experiment we selected 20 TRANSFAC PWMs
that represent proteins which are involved in enhanceo-
some assembly (Additional file 1: Table S1). Figure 1
presents the enhanceosome sequence together with posi-
tions and orientation of the PWM hits along that
sequence. Among all predictions returned by TACO,
some did not match the structure of the dimer binding the
enhanceosome as known from the literature. Since the 3D
structure of the enhanceosome may have slightly affected
the offset of the involved dimers through allosteric effects,
in selecting the predictions we allowed a ±2 bp mar-
gin on the predicted offset with respect to the offset
derived from the published enhanceosome structure. In
this way we ended up with 137 predictions for the human
enhanceosome (Additional file 2). A similar table with
mouse predictions was also obtained (Additional file 2).
In human the total number of different predicted dimer
structures was 16, while for mouse it was 7. They covered
36 for human, and 14 for mouse cell types. One human
cell type (Treg_Wb78495824) had 12 different dimers pre-
dicted (75% of all dimers). In mouse the cell type with the
largest number of predicted dimers (5) was Treg (71% of
all dimers).
Following the positions of hits in the enhanceosome
we grouped our predictions into four groups: HMG-A;
ATF2 (representing the enhanceosome dimer consisting
of HMG I, the leftmost binding, with ATF-2/c-Jun activa-
tor), ATF2; HMG-B (representing the dimer consisting of
ATF-2/c-Jun activator with HMG I, the middle binding,
IRF-A; IRF-B (homodimer of IRF proteins), and IRF-B;
HMG-C (representing the dimer consisting of IRF and
HMG I, the rightmost binding). Figure 2 shows posi-
tions of predicted dimers mapped to the enhanceosome
sequence; it also shows the above mentioned four groups
of predicted dimers. Note that 13 of these 16 genome-
wide overrepresented dimer structures were character-
ized by a motif spacing 1 bp tighter than in the original
enhanceosome.
Table 1 shows the breakdown of predicted dimers in the
human enhanceosome with respect to dimer types. It also
indicates the number of cells a given dimer was predicted
in. In boldface are shown dimers that were also predicted
in mouse. A similar table for mouse predicted dimers is
given in Additional file 1: Table S2. It is noticeable that
only dimers found in the highest number of cell types were
those predicted both in human and mouse enhanceo-
some. Dimer M00750; M00801 (of type HMG-A; ATF2)
was predicted in 24 cell types in human (67% of all human
cell types that contained a predicted dimer) and in all the
14 cell types that contained a predicted dimer in mouse.
It is interesting to notice that in both cases when a given
dimer type was predicted in the largest number of cell
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Fig. 2 Predicted dimers mapped to the enhanceosome sequence. Positions of predicted dimers are mapped to the human enhanceosome
sequence. Each rectangle represents one dimer (except the one with two asterisks next to it, which actually represents two dimers of exactly the
same structure, due to two motif occurrences that represent ATF2). Red rectangles indicate the cases where motifs found in the enhanceosome
have 1 bp wider spacing than the genome-wide dimers; gray rectangles indicate the cases where the spacing matches. Dimers are grouped
according to their type into four groups. Dimers that were predicted both in human and in mouse are marked with an asterisk. Position of each
motif composing a dimer is indicated with an arrow; orientation of the arrow corresponds to the orientation of the occurrence of this motif
types (HMG-A; ATF2 and IRF-A; IRF-B) the cell types
related to a given dimer are very much the same. Table 2
illustrates this situation – all rows, except the last two, are
identical. A very similar property holds for the dimer type
IRF-A; IRF-B (Additional file 1: Table S3).
Predicted dimer binding sites are enriched in regulatory
states
In order to check whether positions of instances of pre-
dicted dimers are enriched in chromatin states associated
with regulatory function, we used the data deposited from
the ENCODE Project for Broad ChromHMM [14]. In this
version there are ChromHMM data (.bed files) available
for 11 human cell types, out of which four cell types
were present in our study: GM12878, HMEC, HUVEC
and K562. In total, 11 dimers were predicted in the above
mentioned cell types (Table 3).
Predictions are referred to by their hypothesis_id num-
ber. For a given cell type the data from ChromHMM for
that cell type assigns, to each position in open chromatin,
Table 1 Breakdown of predicted dimers in human cell types with respect to dimer types
HMG-A; ATF2 ATF2; HMG-B IRF-A; IRF-B IRF-B; HMG-C
M00750; M00172 (22) M01010; M00801 (6) M00972; M00772 (10) M01010; M01881 (1)
M00750; M00188 (22) M01010; M00172 (3) M00972; M01881 (17) M01881; M01010 (1)







In boldface are indicated the dimers that were also predicted in mouse. Numbers in parentheses show the number of cell types in which the dimer was predicted
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Table 2 Dimers from the HMG-A; ATF2 group predicted in
various human cell types

























Note that M-CD14+_RO01746 is an abbreviation for Monocytes-CD14+_RO01746
one of the 15 possible HMM states that describe predicted
state of activity for that position. A dimer instance may
have more than one state assigned to the genomic locus it
covers. In order to assign a unique state to each instance,
we decided to choose the state of the midpoint of the
instance as representative.
In order to help assessing whether dimer instances
are enriched in regulatory states related to pro-
moter/enhancer elements we divided the set of all
states into two groups: G-plus group consisting of:
‘Strong_Enhancer’, ‘Active_Promoter’, ‘Weak_Promoter’,
and ‘Weak_Enhancer’, with G-minus consisting of
the remaining states. Figure 3 shows a histogram of
ChromHMM states assigned to dimer occurrences, where
group G-minus forms one category, and G-plus is split
into four subgroups, as indicated above. It is quite clear
that overwhelming majority of dimer instances is assigned
a regulatory state in G-plus. In order to assess a p-value
of obtaining at least that many occurrences in G-plus
group, this could be considered as a binomial process.
Table 3 Human dimer instances located within a gene
Dimer-type Dimer Within-gene Total Percent
M00750; M00172 1105 2029 54%
HMG-A; ATF2 M00750; M00188 1141 2123 53%
M00750; M00801 2171 3956 54%
ATF2; HMG-B M01010; M00801 2344 4499 52%
M01010; M00172 1479 2783 53%
IRF-A; IRF-B M00972; M00772 395 707 55%
M00972; M01881 855 1471 58%
M00772; M01881 357 633 56%
M01881; M01881 695 1238 56%
M00453; M01881 46 73 63%
M00972; M00972 358 624 57%
M00772; M00772 95 187 50%
M01881; M00772 122 211 57%
M00972; M00453 37 63 58%
IRF-B; HMG-C M01010; M01881 738 1273 57%
M01881; M01010 239 457 52%
A more detailed statistics is given in (Additional file 1:
Table S4).
Dimer instances are mainly located within introns
Next we investigated how far are located predicted dimer
instances with respect to a nearest gene. Table 3 shows, for
each predicted dimer, the total number of instances (in all
cell types where the dimer was predicted) and the num-
ber of instances that are located within a gene. It clearly
follows from that table that for all dimers most of their
instances are located within a gene, which must be an
intron, since we have masked all the exons. Distribution
of the distances from a dimer instance to the closest gene
is shown in Fig. 4. Observe that dimer instances that are
not located within a gene are rather far from the nearest
gene (median ranging from 46 to 95 kbp, depending on
the dimer). Same observation holds for mouse as well, but
here the spectrum of medians is bit smaller, ranging from
62 to 80 kbp.
Dimer instances located near Transcription Start Site of a
gene are enriched for being part of a computationally
predicted enhancer
As an additional sanity check, we selected all 2663 human
genes that contain within 10 kb for their Transcription
Start Site (TSS) at least one instance of a predicted dimer.
We restricted our attention to only those genes that con-
tain at least three instances within the 10 kb distance from
their TSS. In this way we reduced the number of genes
to 70. Next we applied a computational tool, Billboard
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Fig. 3 Breakdown of ChromHMM states with respect to dimer occurrences. For each predicted dimer in four human cell types: HUVEC, K562, HMEC,
and GM12878, a breakdown is shown between ChromHMM regulatory states (G-plus), split into four groups, and the remaining states that compose
the G-minus group. X-axis shows the number of dimer occurrences
Fig. 4 Distribution of distances from a dimer instance to the closest gene. For each predicted dimer in human cell types, the distribution of basepair
distances from a dimer instance to the closest gene is shown as a boxplot. Grouping of dimers into dimer types is indicated. The boxplots for dimers
that were predicted both in human and in mouse are shown in green
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[15], to predict enhancers within the 20 kb area around
TSS of each of the 70 genes. The salient feature of Bill-
board is that, with the help of an informant species, it
discovers evolutionarily conserved arrangements of TFBS.
Within a short window (here 50 bp) arbitrary permuta-
tions of TFBSs are allowed. For this experiment we chose
five informant species: mouse, rat, macaque, opossum,
and chicken. Of the 70 human genes, six did not have
any ortholog in any of the five informant species, so they
had to be removed from further analysis. The remaining
64 genes had in total 205 dimer instances within ±10 kb
of the TSS. We run Billboard on these 64 human genes
to find positions of predicted enhancers. As a result 183
dimer instances (89% of all considered instances) ended
up within a predicted enhancer (p-value 2.6e − 05). On
average, the number of informant species supporting a
given Billboard prediction was 2.24. Additional file 3 con-
tains information about the selected human genes and the
outcome of this computational experiment.
Gene Ontology enrichment of dimer selected genes
In order to elucidate a potential regulatory function of
predicted dimers we investigated genes which are located
in the neighbourhood of dimer instances. A gene is said
to be selected by a dimer instance if it is the closest gene
to that instance: either the instance is located within the
gene, or else the distance between the midpoint of the
instance and the closest nucleotide position within the
gene is minimal (upstream or downstream). We group
the selected genes, for a given dimer, into 7 sets: those
that contain an instance of the dimer within its introns
(denoted Q0), and those located within 100, 500, 1,000,
5,000, 10,000, and 50,000 bp from an instance of the dimer
are denoted Q1, Q2, Q3, Q4, Q5, and Q6, respectively.
In addition to this, we also performed for each dimer a
global analysis consisting of taking as Qx (x = 0, 1, . . . , 6)
set union of all sets Qx over all considered cell types.
Below we discuss enriched GO terms for dimer selected
genes, separately for each of the four dimer types. We
mainly focus on Q0 sets of genes since for these genes
there were the most statistically significant GO enrich-
ment terms. Here we consider all GO enriched terms
for all gene categories having enrichment with FDR rate
< 0.01 (Additional files 4 and 5). Under this threshold
there were no enriched terms for the dimers of type IRF-B;
HMG-C.
For dimers of type HMG-A; ATF2 there were only 5
cell types with many enriched terms for genes in set
Q0 (HMVEC-dAd, HMVEC-dBl-Ad, HMVEC-dLy-Neo,
HMVEC-dNeo, HMVEC-LBl), all of them being blood
microvascular endothelial cells. The biological process
(BP) enriched terms for Q0 genes selected by dimers of
this type are: ‘regulation of Rho protein signal transduc-
tion’, ‘focal adhesion assembly’, ‘regulation of phosphate
metabolic process’, ‘establishment or maintenance of cell
polarity’, and ‘actin cytoskeleton organization’. For cellu-
lar component (CC) domain the enriched terms include:
‘focal adhension’, ‘cytoskeleton’, ‘cell cortex’, ‘neuron pro-
jection’, and ‘cell-cell junction’. Finally, for molecular func-
tion (MF) domain we have the following enriched terms:
‘cytoskeletal protein binding’, ‘Ras/Rho guanyl-nucleotide
exchange factor activity’, and ‘protein tyrosine kinase
activity’. It is also noticeable that the set of genes located
within 500 bp of a dimer instance (Q2 query) has enriched
a BP term ‘positive regulation of tyrosine phosphoryla-
tion of STAT protein’. As an illustration, Fig. 5 shows a
complete set of enriched GO terms for just one dimer
(M00750; M00172) of type HMG-A; ATF2 for all the 17
human cell types that this dimer was predicted.
An interesting collection of enriched terms is for genes
selected by dimers of type ATF2; HMG-B. For BP domain
the enriched terms include: ‘axon guidance’, ‘cell junction
assembly’, ‘regulation of signal transduction’, ‘transmem-
brane receptor protein tyrosine kinase signalling path-
way’, ‘wound healing’, and ‘actin filament organization’.
Enriched GO terms for CC domain include: ‘neuron pro-
jection’, ‘adherence junction’, and ‘actin cytoskeleton’, while
terms for MF domain are: ‘actin binding’, and ‘Rho/Ras
guanyl-nucleotide exchange factor activity’.
The third dimer type, IRF-A; IRF-B, does not have a very
pronounced set of enriched terms for Q0 genes. Instead
it has an interesting set of enriched terms for Q2–Q3 sets
of genes. Notably, the BP enriched term ‘ISG15-protein
conjugation’ is enriched for all queries Q1–Q5. A BP
term ‘negative regulation of type I interferon production’
is enriched for many cell types. Likewise the BP terms
‘defense response to virus’, ‘defense response to other
organism’, and ‘NLS-bearing protein import into nucleus’
are enriched for Q2 and Q3 queries. Also query Q6 has
a very wide spectrum of BP enriched terms. These are
mainly involved in defense response and in the adaptive
immune system.
Enriched GO terms for Q0 and Q6 selected genes are
similar between human andmouse
In order to assess similarity of enriched terms between
human and mouse we performed the following experi-
ment. For a given dimer D that was predicted in human
and mouse cell types we consider all pairs of cell types
(CH ,CM) such that D was predicted in human cell type
CH , as well as in mouse cell type CM. For i = 0, . . . , 6,
let G(i)H denote the Qi selected genes that are also selected
by dimer D in CH . In a similar way we define genes G(i)M









of all GO terms enriched for genes in G(i)H and in G
(i)
M ,
respectively. We assess statistical significance of the inter-
section of these two sets by performing Fisher’s exact test,
Jankowski et al. BMC Systems Biology  (2016) 10:14 Page 8 of 13
Fig. 5 Heat map for Gene Ontology enriched terms. Enriched Gene Ontology terms associated with genes that contain instances of the dimer
M00750; M00172, shown as a heatmap. This dimer is of type HMG-A; ATF2. We show enrichment p-values for the global instances (set union of all
instances of the same dimer in all cell types) and for each of the 17 human cell types in which the dimer was predicted
considering as universe the set of all GO terms that can be
assigned to human or mouse genes, correspondingly.
We address here only dimers of type HMG-A; ATF2 and
IRF-A; IRF-B. Only GO terms for genes selected by Q0
and Q6 queries had statistically significant intersections
between human and mouse. Table 4 contains mean values
for these distributions. We also present there p-values for
Fisher’s exact test for global instances for each dimer and
each pair of cell types (Additional file 6). It clearly follows
from that table that enriched GO terms for Q0 selected
human and mouse genes are quite similar to each other
for dimers of type HMG-A; ATF2. It is less so for dimers
of type IRF-A; IRF-B and for Q6 selected genes, but still in
some cases the enriched terms are reasonably similar.
Q0 and Q6 selected genes for human andmouse are in
close homology
In the same spirit we assessed similarity of genes selected
by the same dimer in human and in mouse. Here we
have to preprocess the data so that Fisher’s exact test
is applicable. Given a dimer D and selected genes: GH ,
in human and GM, in mouse, the main issue is how to
interpret intersection of GH and GM. For this end, we
use orthology relation between human and mouse genes.
Since this relation is of many-to-many kind, it follows
that we should take the smallest partition of GH and
the smallest partition of GM, so that if two genes g1, g2
in one set are orthologs to a common gene in another
set, then g1, g2 belong to the same block of the partition.
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Table 4 p-values (minus log to the base 10 of reported p-values) for the Fisher’s exact test for similarity of GO terms enriched for
human and mouse selected genes. Here we report only Q0 and Q6 selected genes
Dimer type Dimer p-value Q0 global Best Q0 p-value p-value Q6 global Best Q6 p-value
HMG-A; ATF2 M00750; M00172 78.96 80.15 (HdL/416) 0.35 3.31 (HdA/Spl)
HMG-A; ATF2 M00750; M00188 72.44 40.97 (HLB/416) 1.51 1.73 (HLL/416)
HMG-A; ATF2 M00750; M00801 62.74 159.94 (HdA/CH) 0.37 14.16 (Th2/Thy)
IRF-A; IRF-B M00772; M01881 0.61 2.01 (GM/Spl) 3.02 3.01 (CD/A20)
IRF-A; IRF-B M00972; M00772 0.59 2.59 (GM/TRA) 13.22 10.42 (CD/TR)
IRF-A; IRF-B M00972; M01881 7.27 9.22 (Mon/Bcl) 2.12 16.86 (ThW/TR)
IRF-A; IRF-B M01881; M01881 7.94 10.16 (ThW/Bcl) 8.55 5.41 (CD/TR)
Column ‘p-value Q0 global’ refers to p-value of Fisher’s exact test for globaly selected genes (set union of all genes selected by the same dimer in different cell types). Column
‘best Q0 p-value’ shows minus log to the base 10 of the best reported p-value, names in brackets are cell types in human/mouse for which this p-value was achieved. Same
explanation applies to Q6. Here are the abbreviations of the cell type names: (human) HdL = HMVEC-dLy-Neo, HdA = HMVEC-dAd, HLB = HMVEC-LBl, HLL = HMVEC-LLy,
GM = GM12865, CD = CD2+_RO01778, Mon = Monocytes-CD14+_RO01746, ThW = Th2_Wb54553204; (mouse) 416 = 416B, Spl = Spleen, CH = CH12, Thy = Thymus,
TRA = TReg-Activated, TR = TReg, Bcl = B-cell_(CD19+)
See Methods section for a more detailed description.
Now, intersection between GH and GM is interpreted as
the number of partition blocks, say of GH , that have a
corresponding partition block in GM related by at least
one orthology relation between members of these blocks.
The universe is then taken as the number of equiv-
alence classes in the set union of human and mouse
genes.
Table 5 contains information about p-values assigned
to Fisher’s exact test for similarity of Q0 and Q6 selected
human/mouse genes under global dimer approach, as well
as information about a pair of cell types (human/mouse)
that have the best p-value for the given dimer. It clearly
follows from this table that Q0 selected genes for dimers
of type HMG-A; ATF2 exhibit higher similarity between
human and mouse than for dimers of type IRF-A; IRF-B.
However, for the latter dimers similarity between selected
genes is still quite clearly visible. Additional file 7 contains
detailed information about p-values assigned to Fisher’s
exact test for each dimer and each pair of human-mouse
cell types.
Discussion
Of the 16 predicted dimers in the human enhanceosome,
7 dimers were constructed from an architectural pro-
tein of High Mobility Group I(Y) (HMG I) and one of
the two transcriptional activators: ATF-2/c-Jun and inter-
feron regulatory factor (IRF). In total these heterodimers
fall into three types, depending on their binding location
in the enhanceosome: the leftmost enhanceosome binding
position of HMG I (HMG-A) with ATF-2/c-Jun, ATF-2/c-
Jun with the middle enhanceosome binding position of
HMG I (HMG-B), and IRF with the rightmost enhanceo-
some binding position of HMG I (HMG-C). The remain-
ing 9 dimers constituted homodimeric arrangement of
IRF with itself. It is remarkable that nuclear factor kappa-
light-chain-enhancer complex of activated B cells (NF-κB)
did not show up in this analysis. It should be kept in mind
that dimers predicted by TACO are only those that show
overepresentation in terms of binding instances in a par-
ticular cell type over the background. Hence, if a certain
dimer was not predicted it does not mean that this dimer
configuration is not plausible.
Table 5 p-values (minus log to the base 10 of reported p-values) for the Fisher’s exact test for similarity of dimer selected genes
between human and mouse. Explanation and abbreviations are as in Table 4. Addtional abbreviations: (human) HU = HUVEC, Th1 =
Th1_Wb33676984; (mouse) Zh = ZhBTc4
Dimer type Dimer p-value Q0 global Best Q0 p-value p-value Q6 global best Q6 p-value
HMG-A; ATF2 M00750; M00172 32.93 18.1 (HLB/416) 2.46 2.06 (HU/416)
HMG-A; ATF2 M00750; M00188 35.02 19.54 (HdL/416) 2.17 2.87 (HU/416)
HMG-A; ATF2 M00750; M00801 299.07 60.35 (HU/Zh) 121.63 24.76 (Th1/Spl)
IRF-A; IRF-B M00772; M01881 11.10 6.79 (CD/A20) 2.56 3.05 (ThW/A20)
IRF-A; IRF-B M00972; M00772 10.91 8.32 (Th1/TRA) 0.75 1.26 (Th1/TRA)
IRF-A; IRF-B M00972; M01881 65.49 19.49 (Th2/TR) 12.46 8.28 (Th2/A20)
IRF-A; IRF-B M01881; M01881 50.10 17.43 (CD/A20) 11.9 7.09 (Th1/Bcl)
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In total the dimers were predicted in 36 human cell
types: two from ENCODE Tier 1 (GM12878 and K562),
three from ENCODE Tier 2 (CD20+_RO01778, HUVEC,
and Monocytes-CD14+_RO01746), and the rest of cell
types are from ENCODETier 3.Most of the cells with pre-
dicted dimers are from blood tissues: monocytes, B cells,
B-lymphocyte, T cells, T regulatory cells, and T helper
cells – all of them of normal karyotype, but also some
diseased cells, mainly leukemia (NB4, K562, and CMK).
It is noticeable that for all types of dimers, except ATF2;
HMG-B, the predicted cell types that contain the dimer
are mainly blood cells. For both dimers of type ATF2;
HMG-B the predicted cell types are leukemia (K562),
prostate (normal cell, PrEC), and epithelium (SAEC,
RPTEC, HMEC, and HEEpiC).
We also performed a similar analysis in mouse cell
types. We have found 7 dimers present in 14 cell types.
It is remarkable that the structure (motif pair, offset and
mutual orientation) of all these dimers matched exactly
the structure of dimers predicted in human. It is also
noticeable that the 7 dimers predicted both in human
and in mouse exhibit the highest number of human cells
containing them.
Interestingly, 13 dimer structures predicted in human
out of 16, were characterized by a motif spacing 1 bp
tighter than in the original enhanceosome. What is more
interesting is that the remaining 3 dimers (the ones that
have the same offset as in the original enhanceosome)
are all of the same type HMG-A; ATF2 and are there-
fore located on the enhanceosome leftmost side of the
sequence. All of the above mentioned 13 dimer structures
are located inside the enhanceosome. An additional sup-
port that we are not discussing here is that the above
mentioned 3 dimers are predicted in mouse with exactly
the same offset, and the other 4 mouse dimers, having the
same offset as in human, turn out to be 1 bp tighter than
in the original mouse enhanceosome. A possible mecha-
nistic explanation of this phenomenon is that a 1 bp wider
offset between TFs that are located inside of the big pro-
tein complex which binds the enhanceosome is caused
by the overall three-dimensional structure of the com-
plex, with weaker constraints imposed on the sides of the
enhanceosome complex.
As a sanity check we investigated ChromHMM states
assigned to genomic dimer instances. In an overwhelm-
ing number of cases these instances were assigned to
an enhancer or promoter state. More than half of the
instances are located within a gene (in introns). Moreover,
using an enhancer annotation tool, Billboard, we searched
the ±10 kb area around TSS of human genes that contain
at least three dimer instances. With help of five informant
species, we concluded that in 89% of the 205 instances
they were included in a predicted enhancer. This supports
the hypothesis that the predicted dimers, being part of the
human enhanceosome, are also utilized in the genome by
other enhancers.
In order to analyze genes which contain in their vicin-
ity a dimer instance, we defined 7 groups, which we
call queries: genes containing a dimer instance (Q0),
and queries Q1 through Q6 that consist of genes that
the closest distance to a dimer instance is less than
100, 500, 1000, 5 000, 10,000, and 50,000 base pairs.
Next, for each dimer we performed Gene Ontology
analysis for each of the above mentioned queries. We
have also compared enriched GO terms for similarity
between human and mouse. The performed Fisher’s
exact test suggests that the enriched terms for queries
Q0 and Q6 are significantly similar between human and
mouse. Even stronger similarity is observed for com-
parison of human/mouse genes selected by these two
queries. For this we adopted Fisher’s exact test by utiliz-
ing the orthology relation between human and mouse
genes.
Conclusions
We have performed a comprehensive search of overrep-
resented dimers composed of transcription factors that
constitute the human enhanceosome. We searched over
many cell types, both in human and in mouse. The pre-
dicted dimers were grouped into 4 types, according to
their binding position in the enhanceosome: HMG-A;
ATF2, ATF2; HMG-B, IRF-A; IRF-B, and IRF-B; HMG-
C. Here HMG-{A, B, C} represents three binding sites of
the architectural protein HMG I in the enhanceosome.
No other combinations of TFs and/or architectural pro-
teins were predicted. The majority of cell types in which
these dimers were discovered were various kinds of blood
tissues.
Despite the fact that we allowed for dimer spacing
variability up to ±2 bp comparing to the enhancesome
sequence, most of the predicted dimers were exactly 1 bp
wider than suggested by the motifs within the enhanceo-
some. The remaining 3 dimer predictions were of the
same type HMG-A; ATF2, located on the side of the
enhanceosome. Since in most of the cases the predicted
dimer binding sites were associated with a state of regu-
latory character, we assumed that the role of these dimers
is being a part of enhancers other than the enhanceo-
some. We observe that dimer instances are preferen-
tially located within introns of genes and that those
instances that are located near TSS of a gene are prefer-
entially included in computationally predicted enhancers
(p-value < 2.6e − 05).
Gene Ontology analysis for the groups of genes that
are located near dimer binding sites shows that these
dimers are possibly involved in various kinds of activi-
ties: the first two types seem to be involved in regula-
tion of signal transduction and in Ras guanyl-nucleotide
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exchange factor activity. On the other hand, the third
type of dimers is mainly involved in defense response
and in the adaptive immune system. Predicted dimers
for mouse, even though they form a subset of those
in human, have similar properties. The enriched Gene
Ontology terms for the corresponding human and mouse
genes are similar. Also the corresponding genes, related




We took as the human enhanceosome the 57 bp piece
of DNA located on chromosome 9 (positions 21077989
to 21078045 in genome assembly hg19), which is 44 bp
upstream of the human interferon beta 1 gene IFNB1
(Ensembl ID: ENSG00000171855). Search of a homolo-
gous piece in the mouse genome reveals a region of very
high similarity on chromosome 4 (E-value = 3.7e − 33)
that is located 101 bp upstream of mouse interferon beta
1 gene Ifnb1 (Ensembl ID: ENSMUSG00000048806). We
took for the analysis a sequence from the mouse genome
(assembly mm9) of the same length (57 bp). Human and
mouse enhanceosomes are almost identical: except for the
first position and the last four positions, they differ by only
two mismatches.






It should be noted that in TRANSFAC motif database,
some TF motifs of binding sites already represent dimeric
complexes. In the case of the enhanceosome, this hap-
pens for ATF-2+c-Jun dimer, as well as NF-κB dimer
(p50+RelA). We took these motifs without any further
slicing. Also motifs for the two related TFs: IRF3 and
IRF7 were difficult to discriminate, so we took all such
motifs as representing any of the two TFs. In addition to
this, we also considered HighMobility Group (HMG) pro-
teins that function in the enhanceosome as architectural
proteins which remove the intrinsic bend of the dou-
ble helix and therefore allow binding of transcriptional
activators [8].
A set of 27 motifs was initially selected for further anal-
ysis. We scan the human enhanceosome sequence with
eachmotif with themotif score threshold set in such a way
as to give the balanced threshold of 100, i.e. the threshold
that makes the ratio of false positive rate to false negative
rate at the level of 100 [16]. It turned out that of the 27
motifs only 20 had hits in the enhanceosome above the
set threshold: there were 4 (out of 8) motifs representing
the complex ATF-2+c-Jun; 5 (out of 5) motifs representing
IRF3/IRF7; 7 (out of 8) representing NF-κB complex; and
4 (out of 6) representing HMG motifs. TRANSFAC iden-
tifiers of the selected 20 motifs are reported in Additional
file 1: Table S1.
Generating TACO predictions
We collected DNase I hypersensitivity data for human
(193 narrowPeak files, accounting for 105 cell types) and
for mouse (123 narrowPeak files, accounting for 42 cell
types). This data was generated at the University of Wash-
ington and obtained from the ENCODE Project, Genome
Browser track wgEncodeUwDnase. The list of DNase I
files for human and mouse and the list of corresponding
cell types is given in Additional file 8.
Standalone tool TACO [11] was provided with all the
datasets specified as WeaklySpecificDatasets. As
in the default TACO setting, coding regions and repeti-
tive elements were masked, individual DNase peaks were
excluded if most of the underlying genomic sequence was
masked (RegionMasking = Majority), up to 50,000
DNase peaks with top signalValue from each replicate
were considered (RegionCount = 50000). Deviating
from the default settings, no lower bound was imposed for
the number of instances of predicted dimer in the target
dataset (TargetInstancesThreshold = 1).
Finding nearest gene for a dimer binding site
Each dimer binding site was classified as either located
within a gene (coding part of genes was masked, so it was
located in an intron), or else a distance to the nearest gene
(both upstream and downstream) was calculated. Here we
take the midpoint of the dimer instance and calculate its
distance to the nearest position of a gene (it would be a
Transcription Start Site (TSS), if the gene is located down-
stream, or the end position of a gene, if that gene is located
upstream). Then, for a given distance x (x is one of the dis-
tances 100, 500, 1,000, 5,000, 10,000, and 50,000) and for
a given dimer binding site we report all genes such that
the calculated distance from the dimer binding site is less
than x.
Gene Ontology enrichment analysis
Gene Ontology analysis for the selected genes was per-
formed with help of Biopython [17] and Bio.Ontology
module within it (Koziara K,Wilczynski B: Bio.Ontology –
Python tools for enrichment analysis and visualization of
ontologies, in preparation).
Assessing similarity of dimer selected genes between
human andmouse
In order to assess similarity of selected genes between
human and mouse we have to preprocess the data. Let
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GH and GM be selected genes in human and mouse,
respectively. Let RO be a many-to-many gene orthology
relation between human and mouse. We iteratively build
partitions of GH and GM as follows. Initially all partition
blocks in GH and GM are one-element and the orthol-
ogy between blocks is given by RO. Iteratively, we join two
partition blocks to form a new block (say X) in human
(or in mouse) when they are linked by the orthology rela-
tion to a common block (say Y) in the other species. The
new block X is linked by new orthology relation to Y.
The process terminates when no new blocks to be jointed
exist.
Fortunately, when we run this procedure on the data it
terminates very quickly with only very few blocks having
more than one element.
Additional files
Additional file 1: Supplementary tables. Supplementary tables
providing various kinds of additional information. Table S1 gives a list of
selected PWMs. Table S2 shows predicted dimers in mouse. Table S3
contains dimers from IRF-A; IRF-B group predicted in various human cell
types. Table S4 gives detailed statistics of ChromHMM states assigned to
dimer instances. (PDF 43.3 kb)
Additional file 2: Selected dimer predictions in human andmouse
enhanceosome. The table contains information on the correct dimer
structure that fits the literature data on the enhanceosome. It also contains
various details of the predictions, including structure of the dimer, name of
the cell type, p-value of the prediction, and number of instances in open
chromatin part of the genome. (XLS 87.5 kb)
Additional file 3: Table of inclusion of dimer instances within
Billboard predicted enhancers. Presented are 64 human genes that
contain within ±10 kb of their TSS at least three instances of predicted
dimers. For each of these instances, we report the number of informant
species in which the instance ended up within a predicted enhancer.
(XLS 20 kb)
Additional file 4: Table of Gene Ontology enriched terms. Gene
Ontology enriched terms with FDR < 0.01 for predicted dimers of HMG-A;
ATF2, ATF2; HMG-B and IRF-A; IRF-B types. Column ‘Cell_type’ contains
information about enriched term in the indicated cell type. When this entry
is empty it indicates that the enriched term is with respect to the union of
of all dimer instances, taken over all cell types in which the dimer was
predicted. (XLS 377 kb)
Additional file 5: Visualization of Gene Ontology enriched terms.
Heatmap visualization of the Gene Ontology enriched terms with FDR
< 0.01 for predicted dimers. (PDF 60.1 kb)
Additional file 6: Comparison of human andmouse Gene Ontology
enriched terms. Fisher’s exact test p-values for comparing human and
mouse enriched Gene Ontology terms for the same dimer and for all pairs
of cell types from human and mouse. (XLS 184 kb)
Additional file 7: Comparison of human andmouse dimer selected
genes. Fisher’s exact test p-values for comparing human and mouse dimer
selected genes for all pairs of cell types from human and mouse.
(XLS 360 kb)
Additional file 8: List of human andmouse DNase I hypersensitivity
datasets considered. (XLS 38 kb)
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